Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 1,101 | 592 | 416 | 620 | 980 |
| Gross Profit | 1,101 | 592 | 416 | 620 | 980 |
| Operating Expenses | 31,443 | 29,141 | 31,905 | 22,734 | 24,249 |
| Operating Income | -30,342 | -28,549 | -31,489 | -22,114 | -23,269 |
| Interest Expense | 0 | 0 | 0 | 85 | 13 |
| Other Income | 2,260 | 275 | 1,586 | 137 | 142 |
| Pre-tax Income | -28,082 | -28,274 | -29,903 | -22,062 | -23,140 |
| Net Income Continuous | -28,082 | -28,274 | -29,903 | -22,062 | -23,140 |
| Net Income | $-28,082 | $-28,274 | $-29,903 | $-22,062 | $-23,140 |
| EPS Basic Total Ops | -4.65 | -4.80 | -4.95 | -3.90 | -4.35 |
| EPS Basic Continuous Ops | -4.71 | -4.74 | -5.02 | -4.01 | -4.28 |
| EPS Diluted Total Ops | -4.65 | -4.80 | -4.95 | -3.90 | -4.35 |
| EPS Diluted Continuous Ops | -4.71 | -4.74 | -5.02 | -4.01 | -4.28 |
| EBITDA(a) | $-28,804 | $-27,020 | $-32,786 | $-21,485 | $-21,820 |